News

On September 11–17, 2026, Ekaterinburg hosted the International Youth Festival, a large-scale event that brought together 10,000 young leaders from 191 countries. At the festival running under the motto «Follow Your Dream,» the Medsintez Plant presented its exhibition, showcasing the achievements of the Ural pharmaceutical industry in the field of import substitution.

The updated clinical guidelines for treatment of ARVI in children took effect on September 2, 2026. The document was developed by leading experts from the Union of Pediatricians of Russia, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and the Russian Society of Emergency Medical Care and approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. It fundamentally shifts therapeutic approaches toward enhanced safety and minimal drug burden.

On September 3–4, 2026, Nizhny Novgorod hosted the 2nd Regional Endocrinological Congress: Challenges and Prospects of the Volga Region, with the active participation of the Medsintez Plant. As a strategic company, Medsintez Plant has been ensuring Russia's pharmaceutical security for 25 years. Company's exhibition booth showcased a range of hormonal medications for treatment of type 1 and type 2 diabetes, as well as drugs for infertility treatment through the IVF method.

More than twenty years ago, the Regiony Rossii (Regions of Russia, RR) magazine witnessed the birth of an innovative pharmaceutical production facility in Novouralsk, which had no analogues in the country. Today, the Medsintez Plant is a strategic asset in terms of national pharmaceutical security, a recognized industry leader, a National Champion, and a winner of prestigious awards. The secret behind the success of the Ural school of pharmaceuticals and biotechnology is explored in this article by RR.

On July 7, the Academician A. P. Aleksandrov House of Scientists at the National Research Center Kurchatov Institute hosted the presentation of winning technological proposals from the Russian Science Foundation (RSF) competition for grants in memory of the prominent scientist Evgeny Velikhov. The event was attended by Andrei Fursenko, Aide to the President of the Russian Federation and Chairman of the RSF Board of Trustees; Yulia Dyakova, Director of the National Research Center (NRC) Kurchatov Institute and member of the RSF Board of Trustees; Elena Popova, Deputy Director General of the RSF; as well as representatives of the winning companies, members of the Russian Academy of Sciences, and members of the scientific and business communities.

Within the framework of the 16th INNOPROM International Industrial Exhibition, Aleksandr Petrov, Chairman of the Board of Directors of Medsintez Plant LLC and Chairman of the Committee for Entrepreneurship in Healthcare and Medical Industry of the Ural Chamber of Commerce and Industry, took part in two key events of the business program. At the Sverdlovsk Region stand, a panel discussion Balance of Control and Support: Practice of Confirming the Production of Russian Industrial Products was held, where Aleksandr Petrov presented the standpoint of industrial enterprises in relation to the review of applications under Decree of the Government of the Russian Federation No. 719.

The Association of Medical and Pharmaceutical Manufacturers of the Sverdlovsk Region, a collective member of the Ural Biomedical Cluster, has participated in the CHEMTECH URAL, first specialised forum and exhibition, held from May 26 to 28 in the Ekaterinburg-EXPO International Exhibition Centre. The organization acted as an industry partner for the event, bringing together key players from the pharmaceutical and chemical sectors of the region at its joint booth.

Pharmaceutical Chemistry: Towards Full-Cycle Production round table discussion was held as part of the business program at ChemTech Ural 2026. Alexander Petrov, Chairman of the Board of Directors of Medsintez Plant LLC, was the keynote speaker at the event.

Medsintez Plant, one of Russia's leading manufacturers of insulins and drugs for the therapy of socially significant diseases, traditionally participated in the 11th (32nd) National Congress of Endocrinologists with International Participation. The event, themed Personalized Medicine in Endocrinology: From Fundamental Science to Clinical Practice, took place from 26 to 29 May in Moscow.

In 2025, the Governor of the Sverdlovsk Region, Denis Vladimirovich Pasler, signed a decree awarding the Regional Head's Certificate of Honour to Alexey Borisovich Podkorytov, CEO of Medsintez Plant LLC.

In May 2026, Medsintez Plant LLC, the leading pharmaceutical enterprise in the Ural region, won the Chemical Industry category at the 10th anniversary of the annual Ural Industrialists and Entrepreneurs «Number One» Awards.